Cite
CR1-expressing retinal pigment epithelium as a combined cell/complement therapy for age-related macular degeneration
MLA
Eva M Zsigmond, et al. “CR1-Expressing Retinal Pigment Epithelium as a Combined Cell/Complement Therapy for Age-Related Macular Degeneration.” Molecular Immunology, vol. 102, Oct. 2018, pp. 214–15. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi...........605bcd8423231e0538d6e7fe7ffcce8d&authtype=sso&custid=ns315887.
APA
Eva M Zsigmond, John L. Mazzilli, Rick A. Wetsel, Stacey L. Mueller-Ortiz, & Ken Simmons. (2018). CR1-expressing retinal pigment epithelium as a combined cell/complement therapy for age-related macular degeneration. Molecular Immunology, 102, 214–215.
Chicago
Eva M Zsigmond, John L. Mazzilli, Rick A. Wetsel, Stacey L. Mueller-Ortiz, and Ken Simmons. 2018. “CR1-Expressing Retinal Pigment Epithelium as a Combined Cell/Complement Therapy for Age-Related Macular Degeneration.” Molecular Immunology 102 (October): 214–15. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi...........605bcd8423231e0538d6e7fe7ffcce8d&authtype=sso&custid=ns315887.